KRAS and non-small cell lung carcinoma: Works aiming to classify EGFR and KRAS mutation status in NSCLC utilizing ML-based radiomics or deep learning approaches are present in literature, including the work of Liu et al. [20], Dong et al. [21], Koyasu et al. [22], Morgado et al. [23], and others.